IP Stock Analysis: International Paper | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 22.849m USD | 12M Return: -3.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 223M
Qual. Beats: 0
Rev. Trend: 87.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
International Paper Company (NYSE: IP) is a global producer of renewable fiber-based packaging, operating across North America, Latin America, Europe, South America, and North Africa. The company runs through two reportable segments: Packaging Solutions North America and Packaging Solutions EMEA. Its product portfolio includes linerboard, medium, whitetop, and saturating kraft, which the company converts into corrugated boxes, bulk bins, shipping containers, and specialty packaging at its converting facilities. End markets span food and beverage, agriculture, industrial manufacturing, personal care, pharmaceuticals, and consumer goods. International Paper was founded in 1898 and is headquartered in Memphis, Tennessee. It is classified in the Materials sector under the GICS sub-industry of Paper & Plastic Packaging Products & Materials.
The company sits within the containerboard and corrugated packaging segment of the materials industry, whose output is widely recyclable and tied to broader supply chain, e-commerce, and industrial shipping demand. Large integrated producers like International Paper typically combine pulp and paper mills with downstream converting operations to capture additional margin beyond the sale of base containerboard.
- DS Smith acquisition synergy capture drives margin expansion
- Containerboard pricing pressured by demand normalization and new capacity
- Capital returns resume as leverage declines post DS Smith integration
| Net Income: -3.44b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 1.63 > 1.0 |
| NWC/Revenue: 3.05% < 20% (prev 10.84%; Δ -7.79% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.65b > Net Income -3.44b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (529.5m) vs 12m ago -0.58% < -2% |
| Gross Margin: 27.75% > 18% (prev 28.30%; Δ -0.55% > 0.5%) |
| Asset Turnover: 61.35% > 50% (prev 51.76%; Δ 9.59% > 0%) |
| Interest Coverage Ratio: -9.54 > 6 (EBIT TTM -3.00b / Interest Expense TTM 315.0m) |
| A: 0.02 (Total Current Assets 8.24b - Total Current Liabilities 7.51b) / Total Assets 36.5b |
| B: 0.12 (Retained Earnings 4.44b / Total Assets 36.5b) |
| C: -0.08 (EBIT TTM -3.00b / Avg Total Assets 39.4b) |
| D: 0.66 (Book Value of Equity 14.5b / Total Liabilities 22.1b) |
| Altman-Z'' = 0.70 = B |
| DSRI: 0.74 (Receivables 4.25b/5.22b, Revenue 24.2b/21.9b) |
| GMI: 1.02 (GM 28.30% / 27.75%) |
| AQI: 0.97 (AQ_t 0.35 / AQ_t-1 0.36) |
| SGI: 1.10 (Revenue 24.2b / 21.9b) |
| TATA: -0.17 (NI -3.44b - CFO 2.65b) / TA 36.5b) |
| Beneish M = -3.18 (Cap -4..+1) = AA |
As of August 06, 2026, the stock is trading at USD 42.31 with a total of 3,194,067 shares traded. Over the past week, the price has changed by -4.04%, over one month by +9.67%, over three months by +37.63% and over the past year by -3.74%.
Current recommended Stop Loss: 37.80 (which is 10.7% or 2.6 ATR below the current price).
International Paper has received a consensus analysts rating of 3.69. Therefore, it is recommended to hold IP.
- StrongBuy: 5
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 45 | 6.4% |
P/E Forward = 28.9017
P/S = 0.9271
P/B = 1.5248
P/EG = 1.5804
Revenue TTM = 24.2b USD
EBIT TTM = -3.00b USD
EBITDA TTM = -231.0m USD
Long Term Debt = 8.84b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.00b USD (from shortTermDebt, last quarter)
Debt = 10.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 450.0m
Net Debt = 9.41b USD (calculated: Debt 10.1b - CCE 726.0m)
Enterprise Value = 32.3b USD (22.8b + Debt 10.1b - CCE 726.0m)
Interest Coverage Ratio = -9.54 (Ebit TTM -3.00b / Interest Expense TTM 315.0m)
EV/FCF = 65.57x (Enterprise Value 32.3b / FCF TTM 492.0m)
FCF Yield = 1.53% (FCF TTM 492.0m / Enterprise Value 32.3b)
FCF Margin = 2.03% (FCF TTM 492.0m / Revenue TTM 24.2b)
Net Margin = -14.20% (Net Income TTM -3.44b / Revenue TTM 24.2b)
Gross Margin = 27.75% ((Revenue TTM 24.2b - Cost of Revenue TTM 17.5b) / Revenue TTM)
Gross Margin QoQ = 27.65% (prev 20.73%)
Tobins Q-Ratio = 0.88 (Enterprise Value 32.3b / Total Assets 36.5b)
Interest Expense / Debt = 3.11% (Interest Expense 315.0m / Debt 10.1b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -2.37b (EBIT -3.00b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.10 (Total Current Assets 8.24b / Total Current Liabilities 7.51b)
Debt / Equity = 0.70 (Debt 10.1b / totalStockholderEquity, last quarter 14.5b)
Debt / EBITDA = -40.74 (negative EBITDA) (Net Debt 9.41b / EBITDA -231.0m)
Debt / FCF = 19.13 (Net Debt 9.41b / FCF TTM 492.0m)
Total Stockholder Equity = 15.4b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.72% (Net Income -3.44b / Total Assets 36.5b)
RoE = -22.39% (Net Income TTM -3.44b / Total Stockholder Equity 15.4b)
RoCE = -12.42% (EBIT -3.00b / Capital Employed (Equity 15.4b + L.T.Debt 8.84b))
RoIC = -8.10% (negative operating profit) (NOPAT -2.37b / Invested Capital 29.3b)
WACC = 7.29% (E(22.8b)/V(33.0b) * Re(9.44%) + D(10.1b)/V(33.0b) * Rd(3.11%) * (1-Tc(0.21)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.25 | Cagr: 20.43%
[DCF] Terminal Value 75.44% ; FCFF base≈492.0m ; Y1≈494.0m ; Y5≈523.3m
[DCF] Fair Price = N/A (negative equity: EV 8.14b - Net Debt 9.41b = -1.27b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.21 | # QB: 0
Revenue Correlation: 87.71 | Revenue CAGR: 12.94% | SUE: -0.79 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.32 | Chg30d=-39.52% | Revisions=-58% | Analysts=2
EPS current Year (2026-12-31): EPS=1.33 | Chg30d=-3.46% | Revisions=-25% | GrowthEPS=+765.9% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=2.94 | Chg30d=+9.99% | Revisions=+0% | GrowthEPS=+120.6% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: -53% (up=2, down=10)